We suggest that the development of CVRFs in this population may be influenced by two risk genotypes characteristic of variants in well-studied genes for hypertension (rs1799983) and dyslipidemia (rs693) and by chemerin as well. The gene discussed is RARRES2; the disease is metabolic syndrome.